Tag: Global Dentistry Award

Johanna Gaß | Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Johanna Gaß | Dentistry | Best Researcher Award

Private Practice, Germany

Dr. Johanna Alexandra Gaß, M.Sc., is an emerging expert in periodontology, implant therapy, and aesthetic restorative dentistry, recognized for her evidence-based approach and scientific precision. She completed her Doctorate in Medicine (magna cum laude) at the University Hospital Heidelberg, where her research focused on the prognostic relevance of genetic signatures in head and neck squamous cell carcinoma—an interdisciplinary study bridging molecular oncology and clinical outcomes. Her academic foundation is strengthened by a Master of Science in “Parodontologie und Implantattherapie” from the Dresden International University (DIU), awarded with highest distinction. Professionally, Dr. Gaß has gained extensive clinical and research experience through her work in leading dental and periodontal practices in Frankfurt and Berlin, combining clinical excellence with innovative methodologies in advanced implantology and minimally invasive periodontal therapy. Dr. Gaß has contributed several peer-reviewed publications in high-impact journals such as International Journal of Cancer and Clinical Advances in Periodontics, alongside conference presentations at prestigious national meetings including the DGParo Annual Congress. Her research on ceramic veneer restorations in periodontally compromised patients and cathepsin-related mechanisms in periodontal disease demonstrates her ability to integrate translational research with clinical applicability. With growing scholarly recognition, her academic output includes multiple collaborative works with leading clinicians and researchers across Germany, emphasizing the importance of interdisciplinary integration between basic science and clinical dentistry. Her research and clinical practice focus on digitalization in dental workflows, regenerative periodontal therapy, and personalized treatment planning—fields central to the modernization of oral healthcare. As a B. Braun Foundation Scholar and Young Speaker for the ARPA Foundation, she has demonstrated leadership and commitment to advancing professional education. Dr. Gaß’s contributions extend beyond the clinic, influencing dental science through research, teaching, and innovation, aimed at improving global oral health outcomes and promoting sustainable, patient-centered dentistry.

Profile: ORCID

Featured Publications

  1. Bäumer, A. M., Riemer, C. T., Büsch, C., Körner, G. A., & Gaß, J. A. (2025). Patient satisfaction among periodontally stable patients with veneer restorations—A retrospective study. Clinical Advances in Periodontics.

  2. Gaß, J. A., Büsch, C., Körner, G. A., & Bäumer, A. M. (2023). Ceramic anterior veneer restorations in periodontally compromised patients: A retrospective study. Clinical Advances in Periodontics.

  3. Plath, M., Gaß, J., Hlevnjak, M., Li, Q., Feng, B., Pastor Hostench, X., Bieg, M., Schroeder, L., Holzinger, D., Zapatka, M., et al. (2021). Unraveling most abundant mutational signatures in head and neck cancer. International Journal of Cancer, 148(1).

Dr. Johanna Gaß’s work bridges scientific research and clinical innovation in periodontology and implant therapy, advancing evidence-based, minimally invasive treatments that enhance long-term oral health outcomes. Her integration of digital dentistry, regenerative approaches, and translational research fosters global progress toward personalized, sustainable, and patient-centered dental care.

Travis Nelson | Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Travis Nelson | Dentistry | Best Researcher Award

University of Washington, United States

Dr. Travis M. Nelson, DDS, MSD, MPH, is a distinguished pediatric dentist and academic leader with extensive expertise in clinical practice, research, and education. He earned his BA from Walla Walla College in 2003, DDS from Loma Linda University in 2007, and MSD/MPH from the University of Washington in 2010. Currently a tenured Associate Professor at the University of Washington, he has held multiple academic appointments, including Clinical and Tenure-Track Associate Professor, Chair of the Department of Pediatric Dentistry, Interim Predoctoral Director, Graduate Program Director, and Acting Chair, demonstrating strong leadership and commitment to advancing pediatric oral health education. Dr. Nelson’s professional experience is complemented by his service on the medical staff at Seattle Children’s Hospital and active involvement in professional organizations, including the American Academy of Pediatric Dentistry, Western Society of Pediatric Dentistry, and American Dental Education Association. His research interests focus on pediatric oral health, early childhood caries prevention, dental sedation and anesthesia, and improving access to dental care for children with special needs. He has authored 37 publications with 521 citations and an h-index of 12, reflecting significant contributions to the scientific literature. Dr. Nelson is highly skilled in clinical pediatric dentistry, procedural sedation, dental public health research, and interdisciplinary program development. His numerous awards and honors include the Law Lewis Endowed Chair, multiple UW Pediatric Dentistry Resident Teaching Awards, Jerome B. Miller “For the Kids” Award, recognition as a Top Dentist by Seattle Metropolitan Magazine, and multiple national and international research fellowships and scholarships. He has also mentored numerous graduate students and residents, guiding impactful research projects on pediatric sedation, dental behavior, and preventive care. Overall, Dr. Nelson’s career exemplifies a seamless integration of clinical excellence, innovative research, and educational leadership, positioning him as a leading figure in pediatric dentistry whose work continues to advance knowledge, improve clinical outcomes, and foster the development of future dental professionals.

Profile: Scopus

Featured Publications

  1. Nelson, T. M., Berg, J. H., Bell, J. F., Leggott, P. J., & Seminario, A. L. (2011). Assessing the effectiveness of text messages as appointment reminders in a pediatric dental setting. Journal of the American Dental Association, 142(4), 397–405.

  2. Nelson, T. M. (2011). The key to caries prevention. Dimensions of Dental Hygiene, 9(7), 48–50, 52–53.

  3. Nelson, T. M. (2012). The consequences of convenience. Dimensions of Dental Hygiene, 10(2), 30–32, 34.

  4. Nelson, T. M. (2013). An improved interim therapeutic restoration (ITR) technique for management of anterior early childhood caries. Pediatric Dentistry, 35(4), 124–128.

  5. Nelson, T., & Nelson, G. (2013). The role of sedation in contemporary pediatric dentistry. Dental Clinics of North America, 57(1), 145–161.

Dr. Travis M. Nelson’s work advances pediatric oral health by improving early childhood caries prevention, optimizing sedation and anesthesia protocols, and expanding access to dental care for children with special needs. His research and educational initiatives bridge clinical practice and public health, fostering healthier communities and shaping the next generation of dental professionals globally.

Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Humanitas Castelli, Italy

Dr. Gabriele Cortina is an accomplished Orthopaedic and Traumatology Specialist recognized for his excellence in sports medicine, knee surgery, and joint reconstruction. He obtained his secondary diploma with distinction from Istituto Magistrale Luigi Pietrobono in Alatri (2006–2011) and earned his Laurea Magistrale a Ciclo Unico in Medicina e Chirurgia with 110/110 e lode from the Università Campus Bio-Medico di Roma in 2017, followed by professional qualification as a Medico-Chirurgo from Università degli Studi di Roma Tor Vergata (2018) and a specialization in Orthopaedics and Traumatology with 50/50 e lode from Campus Bio-Medico di Roma in 2023. Professionally, he serves as an orthopaedic surgeon at Cliniche Humanitas Gavazzeni-Castelli in Bergamo, Clinica Pierangeli in Pescara, and Clinica Santa Teresa in Isola del Liri, while also completing a prestigious Sport Medicine and Knee Surgery Fellowship at ICATME, Barcelona, under Prof. J.C. Monllau. His previous roles include specialization training at Humanitas Gavazzeni and Castelli Clinics and observerships in shoulder and hip surgery at Clinica Villa Verde (Fermo) and Villa Ulivella (Firenze). Dr. Cortina’s research interests focus on orthopaedic biomechanics, joint preservation, rehabilitation protocols, and regenerative therapies. His notable publications include studies on rotator cuff repair, osteoarthritis, kinematic knee alignment, and adipose tissue injection therapy in reputed journals such as The Knee, Osteology, Journal of Surgical Case Reports, and Journal of Experimental Orthopaedics. He is fluent in Italian and proficient in English and has actively participated in international conferences and cadaveric training courses across Europe, including SIAGASCOT, CADLAB Cologne, and M.O.R.E. Knee Learning Center. His research skills encompass clinical data analysis, surgical innovation, and multidisciplinary collaboration. Honors include multiple cum laude academic distinctions and recognition as a finalist in the LiGca-Lab Program by SIAGASCOT. In conclusion, Dr. Cortina embodies the fusion of clinical precision and academic depth, contributing to the advancement of modern orthopaedics through evidence-based practice, cross-border collaboration, and a lifelong commitment to improving musculoskeletal health.

Profiles: Scopus|ORCID

Featured Publications

  1. Cortina, G., Antuofermo, S. M., Papalia, G. F., Cortina, R., Condello, V., Perelli, S., Monllau, J. C., & Madonna, V. (2025). Limited clinical benefit of medial meniscus posterior root repair combined with high tibial osteotomy in varus knee osteoarthritis: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.
  2. Cortina, G., Collarile, M., Condello, V., Orlandi, R., Russo, A., Madonna, V., & Pieracci, N. (2021). Spinal hematoma after total knee arthroplasty: A case report. Journal of Surgical Case Reports.
  3. Berton, A., De Salvatore, S., Candela, V., Cortina, G., Lo Presti, D., Massaroni, C., Petrillo, S., & Denaro, V. (2020). Delayed rehabilitation protocol after rotator cuff repair. Osteology, 1(1), 3.
  4. Cortina, G. (2020). Physical activity for the treatment of chronic low back pain in elderly patients: A systematic review. Journal of Clinical Medicine, 9(4), 1023.
  5. Cortina, G. (2019). New trends in treatment of osteoarthritis: “From cells to metal”. A case report of simultaneous different approach to bilateral hip osteoarthritis. Annals of Case Report.

Dr. Gabriele Cortina’s work advances the field of orthopaedic science through innovative approaches in joint reconstruction, sports medicine, and regenerative therapy, bridging clinical excellence with translational research. His contributions enhance surgical outcomes, improve patient mobility, and foster global innovation in minimally invasive and evidence-based orthopaedic care.

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: Scopus | ORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease

 

Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Published on by World Science Awards

Dr. Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Researcher from Research Center Hargeisa Group Hospital, Somalia

Dr. Sakarie Mustafe Hidig is a dedicated clinical researcher and experienced surgeon with extensive international medical training and practice. Having served in various surgical departments across China and Somalia, he has developed strong expertise in hepatobiliary, gastrointestinal, trauma, and minimally invasive surgeries. Fluent in Somali, English, Chinese, Arabic, and French, Dr. Hidig’s multilingual capabilities have supported his ability to work across cultural and institutional boundaries. He is also a published author in numerous peer-reviewed journals, covering topics such as gastrointestinal bleeding, colorectal cancer surgery, trauma-related interventions, and case reports in orthopedic and abdominal surgery. His academic background, combined with practical knowledge and research insight, enables him to contribute effectively to both clinical operations and scientific advancement. With editorial board roles and peer review certifications, he is actively involved in shaping contemporary medical literature. As a member of multiple medical associations, including the Somali Medical Association, African Medical Association, and China Medical Association, Dr. Hidig continues to impact the regional and global medical communities. His commitment to patient care, clinical research, and academic excellence highlights his suitability for prestigious recognitions such as the Best Researcher Award.

Professional Profile

Education

Dr. Sakarie Mustafe Hidig possesses a strong academic foundation in the field of medicine and surgery, with a clear focus on clinical specialization and language proficiency. He earned his Doctor of Surgery from Zhejiang University, School of Medicine, where he gained advanced knowledge in surgical techniques and clinical research methodologies. Prior to this, he obtained his Master of Surgery from Xinjiang Medical University, where he deepened his understanding of general surgery and patient care. His medical journey began with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Youjiang Medical University for Nationalities, equipping him with comprehensive skills in diagnosing and managing complex medical cases. Complementing his medical training, Dr. Hidig also holds a Diploma from Guangxi University for Nationalities, School of Languages, which reflects his commitment to cultural competence and communication, vital for working in multicultural medical settings. This well-rounded educational pathway reflects both academic excellence and an adaptive mindset, allowing him to function effectively in diverse clinical and research environments. His formal qualifications from esteemed Chinese institutions have positioned him to serve in demanding healthcare systems and contribute significantly to the fields of clinical surgery and medical science.

Professional Experience

Dr. Sakarie Mustafe Hidig has amassed a wealth of professional experience in both clinical and academic settings, working with prestigious hospitals and institutions across Asia and Africa. He has served in the Division of Hepatobiliary and Pancreatic Surgery at the Fourth Affiliated Hospital, School of Medicine, Zhejiang University, where he engaged in complex surgical procedures and clinical research. He also contributed his expertise at the Affiliated Hospital of Youjiang Medical University for Nationalities and the Emergency & Trauma Surgery Department of the First Affiliated Hospital of Xinjiang Medical University, enhancing his capabilities in emergency interventions and trauma management. Additionally, he has worked in the Gastrointestinal Surgery Department of the Affiliated Hospital of Xuzhou Medical University, as well as various roles at Hargeisa Group Hospital and Hargeisa International Hospital, where he handled general and emergency surgeries. His hands-on experience across multiple departments underscores his adaptability and comprehensive surgical proficiency. Throughout his career, Dr. Hidig has consistently demonstrated a commitment to clinical excellence, patient care, and professional development. His experience spans public and private healthcare sectors, reflecting his ability to meet high clinical standards in diverse medical systems.

Research Interests

Dr. Sakarie Mustafe Hidig’s research interests are deeply rooted in clinical surgery, trauma medicine, and gastrointestinal disorders. He has explored a wide range of topics, from emergency surgery for severe chest trauma to the application of cutting-edge procedures in minimally invasive colorectal surgeries. His research often centers on improving surgical outcomes, reducing post-operative complications, and applying innovative diagnostic tools in clinical settings. He has shown a strong interest in analyzing rare and complex medical cases, such as small bowel bleeding associated with hematologic malignancies or arterial gastrointestinal fistulas, which reflect his dedication to solving challenging clinical problems. Furthermore, he is interested in comparative pharmacological studies, such as those involving amiodarone and propafenone in arrhythmia treatment, indicating his interdisciplinary approach to research. His work in knee arthroplasty and bone tumor management shows his commitment to improving orthopedic surgical care. Overall, Dr. Hidig’s research aims to bridge clinical practice with scientific inquiry, enabling evidence-based improvements in surgical procedures and patient outcomes. His interests continue to expand as he contributes to both routine and specialized areas of medical research, with a vision for developing patient-centered, efficient, and innovative surgical interventions.

Research Skills

Dr. Hidig possesses a robust set of research skills that complement his clinical expertise. He is proficient in conducting literature reviews, designing and implementing clinical research protocols, analyzing medical data, and publishing in peer-reviewed journals. A notable strength is his capability in SPSS data analysis, which he applies in interpreting surgical outcomes and clinical trials. His experience as a peer reviewer and editorial board member has refined his understanding of research quality and scholarly communication. He also excels in case study documentation, having authored several rare case reports that have been published internationally. His skills extend to laparoscopic and minimally invasive surgical techniques, where he has not only practiced but also contributed to methodological advancements through his research. Additionally, he demonstrates competence in Microsoft Office tools, crucial for creating presentations, reports, and manuscripts. With an interdisciplinary approach, he often integrates clinical observations with evidence-based research to produce impactful findings. His multilingual ability aids in cross-border collaborations and academic exchanges. Altogether, Dr. Hidig’s research skills empower him to lead clinical studies, contribute to scholarly discourse, and innovate within the surgical field.

Awards and Honors

Dr. Sakarie Mustafe Hidig has been recognized by multiple esteemed medical and research organizations for his academic and professional contributions. He holds the distinction of being a Young Research Fellow Member of the Somali Association for Science (SAS), reflecting his early recognition as an emerging leader in clinical research. His membership ID SAS/SYRFM/088/2023 signifies his formal acknowledgment within this scholarly body. Additionally, he is a Regular Fellow Member of the International Organization for Academic and Scientific Development (IOASD), which attests to his ongoing engagement in global scientific communities. Dr. Hidig is also a respected member of the Somali Medical Association, the African Medical Association, and the China Medical Association, organizations that honor excellence in healthcare practice and research. Through these affiliations, he has participated in various conferences, professional trainings, and collaborative research initiatives. His editorial board memberships and certifications as a peer reviewer further underscore the trust placed in him by academic journals and the broader research community. These accolades and roles demonstrate his dedication to advancing the frontiers of medical science and his continued influence on international platforms of surgical and clinical research.

Conclusion

In summary, Dr. Sakarie Mustafe Hidig exemplifies the ideal candidate for recognition through the Best Researcher Award. With a solid academic foundation, diverse clinical experience, and an impressive portfolio of research contributions, he brings a multifaceted approach to modern surgical science. His career reflects a continuous commitment to improving patient outcomes, advancing surgical techniques, and promoting scholarly excellence. Fluent in five languages and skilled in both qualitative and quantitative research methods, he seamlessly integrates global perspectives into his practice and publications. Dr. Hidig’s work spans complex case reports, pharmacological studies, trauma and gastrointestinal surgery, and orthopedic procedures, demonstrating a wide scope of knowledge and versatility. His active participation in academic communities, professional societies, and editorial review boards further enhances his reputation as a leader in the field. As he continues to make meaningful contributions to healthcare and clinical research, his achievements serve as a benchmark for aspiring medical professionals. Recognizing his efforts through this award would not only honor his past accomplishments but also encourage continued innovation and collaboration in the global medical community.

Publications Top Notes

  1. Exploring the Role of m7G Modification in Cancer: Mechanisms, Regulatory Proteins, and Biomarker Potential
    Authors: Y Zhang, W Xu, C Peng, S Ren, SM Hidig, C Zhang
    Journal: Cellular Signalling, 2024, Article ID: 111288
    Citations: 10

  2. Understanding the Incidence, Screening, and Burden of Cancer in Somalia: A Literature
    Authors: SM Hidig, MM Adan
    Journal: GSJ, Vol. 12 (1), 2024
    Citations: 3

  3. An Overview of Current Pancreatic Cancer Diagnosis and Treatment in China
    Author: SM Hidig
    Journal: IOASD Journal of Medical and Pharmaceutical Sciences, Vol. 1 (1), pp. 60–67, 2024
    Citations: 2

  4. High Hepatocellular Carcinoma Rates in African Nations: Challenges and Possibilities
    Author: SM Hidig
    Journal: International Journal of Recent Research in Interdisciplinary Sciences, 2024
    Citations: 2

  5. Does Mild Flexion of the Femoral Prosthesis in Total Knee Arthroplasty Result in Better Early Postoperative Outcomes?
    Authors: H Zhou, ZR Wu, XY Chen, LS Zhang, JC Zhang, SM Hidig, S Feng, et al.
    Journal: BMC Musculoskeletal Disorders, Vol. 24 (1), Article 711, 2023
    Citations: 6

  6. Diagnostic Value of Mean Platelet Volume Combined with Thromboelastography for Coagulation State after Total Knee Arthroplasty
    Authors: JH Chen, H Zhou, Q Zhang, H Wang, SM Hidig, XY Chen, S Feng
    Journal: Clinical Hemorheology and Microcirculation, Vol. 84 (3), pp. 321–331, 2023
    Citations: 4

  7. The Challenges Facing the Healthcare System in Somalia: A Review and The Way Forward
    Authors: SM Hidig, MHA Rahman Ali, GA Egeh
    Journal: Healthcare Issues, Vol. 3 (1), pp. 6–16, 2024
    Citations: 2

  8. Assessing Healthcare Challenges in Somalia: A 2024 Perspective
    Author: SM Hidig
    Journal: ACH Medical Journal, Vol. 3 (1), pp. 346–347, 2024
    Citations: 2

  9. Traditional Education and Modern Teaching in Somaliland: A Comprehensive Review
    Authors: SM Hidig, AM Saed
    Journal: Journal of Arts Humanities and Social Sciences (GASJAHSS), 2023
    Citations: 2

  10. Promotion Policy and Employee Performance in Golls Telecommunication Company in Dhahar District, Puntland, Somalia
    Author: AM Hidig
    Institution: Kampala International University, 2014
    Citations: 2

 

 

Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Prof. Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Professor and Chairman from Nagasaki University Graduate School of Biomedical Sciences, Japan

Dr. Susumu Eguchi, M.D., Ph.D., F.A.C.S., F.E.B.S., is a globally recognized expert in the field of liver transplantation, hepatobiliary (HPB) surgery, and regenerative medicine. As a Professor and Chairman at the Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Dr. Eguchi has demonstrated outstanding leadership in both clinical and academic arenas. His medical journey is marked by international exposure, significant research contributions, and a wide array of prestigious editorial appointments. He has actively shaped the advancement of liver surgery, particularly focusing on liver regeneration and hepatocyte-based therapies. Dr. Eguchi’s dedication extends beyond national boundaries, with ongoing collaborations as a visiting professor in China and Kazakhstan, strengthening cross-cultural medical education and research. His active participation in hospital management, international medical center leadership, and nuclear disaster preparedness showcases his multifaceted expertise. Additionally, his editorial influence in several leading surgical and transplantation journals underlines his authority and commitment to knowledge dissemination. Throughout his distinguished career, Dr. Eguchi has significantly contributed to the global medical community and is highly regarded for his ability to combine innovative research with practical surgical excellence. His holistic approach and deep impact in the field make him a prominent figure deserving international recognition.

Professional Profile

Education

Dr. Susumu Eguchi’s educational journey is marked by rigorous academic training and international exposure that shaped his expertise in surgery and transplantation. He graduated from the Nagasaki University School of Medicine in 1992, where he developed a solid foundation in medical sciences. His dedication to deepening his knowledge led him to pursue a Ph.D. at the Nagasaki University Graduate School of Biomedical Sciences, Department of Surgery, from April 1994 to March 1998. This doctoral program was pivotal in advancing his surgical and research competencies, particularly in the hepatobiliary and liver transplantation domains. His international perspective was further broadened during his time at Cedars-Sinai Medical Center in the United States from 1994 to 1997, where he gained valuable experience in surgical research. Dr. Eguchi’s education provided him with a comprehensive blend of clinical, academic, and research-based learning that later translated into his significant contributions to the surgical field. The integration of both Japanese and Western medical training environments equipped him with a unique ability to lead innovative research and clinical practices. His academic progression reflects a consistent pursuit of excellence and positioned him to become an influential leader in liver transplantation and regenerative medicine.

Professional Experience

Dr. Susumu Eguchi has an extensive and distinguished professional career spanning over three decades, characterized by leadership roles in clinical practice, international collaborations, and academic governance. His journey began as a surgical trainee at Nagasaki University Hospital, and he further honed his skills at Cedars-Sinai Medical Center, focusing on surgical research. He has served in key positions such as Chief of Surgery at various hospitals, including National Tsushima Hospital and Nakatsushima Hospital. His international clinical fellowship at Groningen University Hospital in the Netherlands specialized in liver transplantation and hepatobiliary surgery, deepening his expertise in these fields. Since 2012, he has been a Professor at Nagasaki University Graduate School of Biomedical Sciences, where he also took on administrative roles, including Deputy Hospital Director and Director of the International Medical Center and Transplant Center. His global influence is evident through his visiting professorship at Guangzhou First Municipal People’s Hospital and Professor Emeritus roles at prestigious institutions in Kazakhstan and China. Dr. Eguchi’s career reflects a perfect balance of surgical excellence, academic leadership, and international outreach. His continuous involvement in both patient care and research highlights his dedication to advancing surgical techniques and improving patient outcomes globally.

Research Interest

Dr. Susumu Eguchi’s research interests are centered around advancing liver transplantation, hepatobiliary surgery, liver regeneration, and regenerative medicine. His work has significantly contributed to the development of liver surgery techniques and the enhancement of liver transplantation outcomes. A major focus of his research involves hepatocyte-based therapy, exploring the potential of regenerative treatments to restore liver function and improve long-term survival rates for patients. Dr. Eguchi is also deeply invested in liver regeneration studies, aiming to unravel cellular and molecular mechanisms that can accelerate or support liver recovery after surgery or damage. His commitment to hepatobiliary and pancreatic (HPB) surgery research integrates both clinical advancements and innovative therapies, addressing complex surgical challenges. Additionally, Dr. Eguchi has shown interest in disaster response and medical preparedness, applying his medical leadership to nuclear disaster situations. His broad research spectrum allows him to contribute to multidisciplinary fields, including surgical innovation, organ preservation, and post-operative recovery strategies. With his global perspective and cross-institutional collaborations, Dr. Eguchi continues to drive progress in improving surgical outcomes and patient care. His pioneering research offers promising solutions in regenerative medicine and solid organ transplantation, pushing the boundaries of modern surgical practices.

Research Skills

Dr. Susumu Eguchi possesses a wide range of research skills that reflect his technical mastery and innovative approach in the field of surgery and transplantation. He is highly skilled in complex liver surgery, hepatobiliary surgical techniques, and organ transplantation procedures. His research capabilities encompass hepatocyte-based therapy development, liver regeneration studies, and regenerative medicine applications. Dr. Eguchi is adept at designing clinical trials, managing multi-institutional research projects, and applying translational research principles to bridge laboratory findings with patient care improvements. His leadership in surgical research has been recognized internationally, contributing to advancements in both surgical methodologies and post-operative patient management. Moreover, Dr. Eguchi demonstrates strong skills in cross-cultural medical collaboration, contributing to the development of global treatment standards. His editorial roles across multiple high-impact journals also indicate his proficiency in critical peer review, scientific writing, and knowledge dissemination. He is experienced in guiding surgical teams, mentoring young researchers, and overseeing international research initiatives. Additionally, his involvement in disaster preparedness reflects his ability to integrate surgical expertise with public health strategies. Dr. Eguchi’s exceptional surgical and research skills collectively position him as a leading figure in the evolution of liver surgery and transplantation.

Awards and Honors

Dr. Susumu Eguchi has received numerous prestigious certifications and honors throughout his distinguished career, which underline his excellence and global recognition in the surgical community. He is a Fellow of the American College of Surgeons (F.A.C.S.), a Fellow of the European Board of Surgery (F.E.B.S.), a Fellow of the International College of Surgeons (F.I.C.S.), and has been recognized as an IASGO Fellow (FASGO) since 2023. His leadership and contributions have earned him honorary titles, such as Professor Emeritus at both Syzganovs’ National Scientific Centre of Surgery in Kazakhstan and The Second Affiliated Hospital to Nanchang University in China. Dr. Eguchi’s exceptional academic contributions are further demonstrated through his numerous editorial appointments in influential journals, including Transplantation, SURGERY, Hepatology Research, Journal of Hepato-Biliary-Pancreatic Science, and Annals of Gastroenterological Surgery. His editorial influence reflects his standing as an expert in the field and his commitment to advancing global surgical knowledge. These accolades not only validate his exceptional skills and research contributions but also emphasize his role as an international leader and innovator in liver transplantation and hepatobiliary surgery.

Conclusion

In conclusion, Dr. Susumu Eguchi is an outstanding and highly accomplished surgeon, educator, and researcher whose contributions to the fields of liver transplantation, hepatobiliary surgery, and regenerative medicine have had a profound impact both in Japan and internationally. His career is marked by an exceptional blend of clinical excellence, academic leadership, and global collaboration. Dr. Eguchi’s extensive research into liver regeneration and hepatocyte-based therapy offers significant advancements in surgical techniques and patient care. His ability to successfully bridge international academic relationships, lead hospital departments, and manage disaster preparedness initiatives highlights his multifaceted expertise. His prestigious fellowships, editorial leadership roles, and international professorships further attest to his global influence and professional recognition. Although future efforts to showcase quantitative research impact, such as citation metrics, could further solidify his academic profile, his achievements to date are exemplary. Dr. Eguchi continues to inspire the next generation of surgeons and researchers through his innovative work, extensive mentorship, and dedication to improving liver surgery outcomes worldwide. Based on his contributions and leadership, he is an exceptional candidate for recognition as a leading researcher and an ideal recipient of the Best Researcher Award.

Publications Top Notes

1. Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus

Authors: Masayuki Fukumoto, Akihiko Soyama, Daisuke Miyamoto, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Mampei Yamashita, Tomohiko Adachi, Kengo Kanetaka, Susumu Eguchi
Year: 2025

2. Association Between Distance to the Transplant Center and Survival Following Living Donor Liver Transplantation

Authors: Hajime Matsushima, Akihiko Soyama, Takanobu Hara, Ayaka Kinoshita, Takashi Hamada, Kazushige Migita, Ayaka Satoh, Hajime Imamura, Tomohiko Adachi, Susumu Eguchi
Year: 2025

3. Effect on short‐term outcomes of the COVID‐19 pandemic following laparoscopic distal gastrectomy and low anterior resection for gastric and rectal cancer: A retrospective study using the Japanese National Clinical Database, 2018–2022

Authors: Masafumi Inomata, Hideki Endo, Tomonori Akagi, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, et al.
Year: 2025

4. Limitations of the proposed lymph node classification in intrahepatic cholangiocarcinoma

Author: Susumu Eguchi
Year: 2025

5. Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan

Authors: Sunao Ito, Arata Takahashi, Hideki Ueno, Shuji Takiguchi, Yoshiki Kajiwara, Yoshihiro Kakeji, Susumu Eguchi, Takanori Goi, Akio Saiura, Akira Sasaki, et al.
Year: 2025

6. Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy: A Case Report

Authors: Yuki Hara, Rin Yamaguchi, Ryota Otsubo, Ayako Fukushima, Eiko Inamasu, Momoko Akashi, Michi Morita, Sayaka Kuba, Susumu Eguchi, Keitaro Matsumoto
Year: 2024

7. Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model

Authors: Daisuke Miyamoto, Kunihito Matsuguma, Kazuhiro Nagai, Takayuki Miyoshi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Takahiro Ochiya, Yasushi Miyazaki, Susumu Eguchi
Year: 2024

8. Current status and future perspectives of robotic liver surgery

Authors: Akihiko Soyama, Takashi Hamada, Tomohiko Adachi, Susumu Eguchi
Year: 2024

9. Essential updates 2022/2023: A review of current topics in robotic hepatectomy

Authors: Tomohiko Adachi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Susumu Eguchi
Year: 2024

10. Short‐term outcomes after liver resection with vascular reconstruction: Results from a study with the National Clinical Database of Japan

Authors: Akihiko Soyama, Hiroyuki Yamamoto, Susumu Eguchi, Atsushi Nanashima, Yoshihiro Kakeji, Yuko Kitagawa, Masafumi Nakamura, Itaru Endo
Year: 2024

Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Published on by World Science Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006